Table 2.
AL-λ (n = 198) | AL-κ (n = 33) | Total | |
---|---|---|---|
Cardiovascular disease | 29 | 6 | 35 |
Infection | 17 | 3 | 20 |
Disease progression | 13 | 3 | 16 |
Treatment complication | 5 | 1 | 6 |
Dialysis complication | 4 | 1 | 5 |
Liver failure | 2 | 1 | 3 |
Lung cancer | 1 | 0 | 1 |
Seizure | 0 | 1 | 1 |
Unknown causes of death | 12 | 2 | 14 |
Deaths | 83 (41.9%) | 18 (54.5%) | 101 (43.7%) |
aThere is no difference between AL-λ group and AL-κ group.